Although the studied genotypes were not associated with any of the BC risk factors, the T/T genotype carriers had some poor prognostic indices in terms of being less likely to be positive for estrogen and progesterone receptors, having a three times higher risk of recurrence, and shorter survival times (<12 months) than other genotypes’ carriers. Here, PGR is linked to breast cancer.